A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...

Marketing needs its Ferris Bueller moment, and that can start by simply spending a bit more of our time with the people, the brands and the creativity which make this such a fun industry to work in, ...

The global flock adhesives market was valued at $1.9 billion in 2019, and is projected to reach $2.9 billion by 2027, growing at a CAGR of 5.7% from 2020 to 2027. Adhesive flocking is a process that ...

In vertebrate retinas, specialized photoreceptors responsible for color vision (cone cells) arrange themselves in patterns ...

The funding will help fund phase 1 and phase 2 proof-of-concept studies for lead candidates CTX203 and CTX114.

Up to 50% of computer users face symptoms of digital eye strain. This condition isn’t just a matter of discomfort, it can ...

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

A new model of brain metabolism – the most complex ever generated –shows how altering key chemicals could restore aged cells ...

A study focusing on analyzing cell models found universality in their movement—an important discovery that could impact both ...

HealthScape Advisors, a leading healthcare payer consulting firm, today announced the release of its annual 2025 Medicare Advantage competitive enrollment report. The report is a collaboration between ...

Seven years into its existence, Character Biosciences is ready to enter the clinic with a pair of experimental medicines ...

Intravitreal UBX1325 helped patients with diabetic macular edema gain vision but failed to meet its primary analysis endpoint in the ASPIRE clinical trial, according to a press release from Unity ...